Skip to content
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors & Reviewers
Sign In
Subscribe
Clinical Topics
View All
Addiction
Anxiety
Bipolar Disorder
Depression
Difficult to Treat Depression
Neurology
OCD
Psychopharmacology
PTSD and Trauma
Schizophrenia
Tardive Dyskinesia
View All
Collections
View All
Academic Highlights
Auvelity: Information from Industry
Banner Alzheimer’s Institute
Clinical & Practical Psychopharmacology
Early Career Psychiatrists
Focus on Childhood and Adolescent Mental Health
Focus on Geriatric Psychiatry
Focus on Psychotherapy
Focus on Suicide
Focus on Psychosis
Focus on Women’s Mental Health
Rounds in the General Hospital
Donna Vermes, MS, NPP
JCP
Letter to the Editor
Memantine in OCD
May 25, 2016
Ketamine may reduce OCD symptoms in some patients, but IV administration is undesirable. Learn whether oral memantine, another NMDA receptor antagonist, would be a good alternative.
Carolyn I. Rodriguez
,
Amanda Levinson
,
Jordana Zwerling
, et al
JCP
Original Research
Six-Month Outcomes From a Randomized Trial Augmenting Serotonin Reuptake Inhibitors With Exposure and Response Prevention or Risperidone in Adults With Obsessive-Compulsive Disorder
April 22, 2015
Edna B. Foa
,
Helen Blair Simpson
,
David Rosenfield
, et al
JCP
Article
Probability and Predictors of First Treatment Contact for Anxiety Disorders in the United States: Analysis of Data From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC)
November 15, 2013
Miren Iza
,
Mark Olfson
,
Donna Vermes
, et al
JCP
Original Research
Six-Month Follow-Up of a Randomized Controlled Trial Augmenting Serotonin Reuptake Inhibitor Treatment With Exposure and Ritual Prevention for Obsessive-Compulsive Disorder
May 15, 2013
Edna B. Foa
,
Helen Blair Simpson
,
Michael R. Liebowitz
, et al